Nuveen Asset Management, LLC 9 Meters Biopharma, Inc. Transaction History

Nuveen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $549,702 - $1.35 Million	-2,114,241 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.33 $24,335 - $38,077	28,630 Added 1.37%	2,114,241 $1.78 Million
Q3 2021 Nov 12, 2021	BUY	$1.03 - $1.41 $898,543 - $1.23 Million	872,372 Added 71.9%	2,085,611 $2.52 Million
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.5 $1.26 Million - $1.82 Million	1,213,239 New	1,213,239 $1.33 Million

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.